Table 3.

Demographic and Baseline Characteristics of Subjects (Blinded Phase) Gabapentin (mg/day)

Demographic and Baseline Characteristics of Subjects (Blinded Phase) Gabapentin (mg/day)
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal